多软膜下横切术治疗药物难治性癫痫:患者水平数据的分解综述
该系统综述从Medline和PubMed提取34项研究、212例患者的个体数据,分析多软膜下横切术(MST)的癫痫结局与并发症。MST联合切除的癫痫无发作率为55.2%,单纯MST为23.9%;颞叶病灶和切除部分病灶是无发作的显著预测因素。MST并发症较常见,包括暂时性单瘫或偏瘫19.8%、暂时性言语障碍12.3%、永久性瘫痪6.6%和永久性言语障碍1.9%。
要点
- MST联合切除的癫痫无发作率为55.2%,单纯MST为23.9%。
- 颞叶病灶与无发作显著相关(OR 4.9;95%CI 1.71, 14.3)。
- 切除部分病灶与无发作显著相关(OR 3.88;95%CI 2.02, 7.45)。
核心结论
- MST是治疗功能区难治性癫痫的有效方法,联合切除部分病灶时无发作机会更大。
- MST报告的无发作率高于迷走神经刺激、深部脑刺激和反应性神经刺激等神经调控治疗,但后者有随机对照试验支持而MST没有。
- MST报告的并发症率高于切除和神经调控治疗。
- 只要进行仔细的风险-获益分析,MST仍是治疗功能区病灶的可行选择。
研究设计与样本
- 系统综述,从Medline和PubMed数据库提取MST操作的患者水平数据,合成34项研究、212例患者的队列。
主要发现
- MST联合切除的患者中55.2%达到癫痫无发作,单纯MST的患者中23.9%达到无发作。
- 颞叶病灶是无发作的显著预测因素(OR 4.9;95%CI 1.71, 14.3)。
- 在可行时切除部分病灶是无发作的显著预测因素(OR 3.88;95%CI 2.02, 7.45)。
- 暂时性单瘫或偏瘫影响19.8%的患者,暂时性言语障碍影响12.3%。
- 永久性瘫痪和永久性言语障碍分别见于6.6%和1.9%的患者。
临床怎么用
- 作者认为,MST仍是治疗功能区病灶的可行选择,前提是进行仔细的风险-获益分析。
局限性
- MST缺乏随机对照试验支持,而迷走神经刺激、深部脑刺激和反应性神经刺激等神经调控治疗有随机对照试验支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multiple subpial transections (MST) are a treatment for seizure foci in nonresectable eloquent areas. OBJECTIVE: To systematically review patient-level data regarding MST. METHODS: Studies describing patient-level data for MST procedures were extracted from the Medline and PubMed databases, yielding a synthetic cohort of 212 patients from 34 studies. Data regarding seizure outcome, patient demographics, seizure type, surgery type, and complications were extracted and analyzed. RESULTS: Seizure freedom was achieved in 55.2% of patients undergoing MST combined with resection, and 23.9% of patients undergoing MST alone. Significant predictors for seizure freedom were a temporal lobe focus (odds ratio 4.9; 95% confidence interval 1.71, 14.3) and resection of portions of the focus, when feasible (odds ratio 3.88; 95% confidence interval 2.02, 7.45). Complications were frequent, with transient mono- or hemiparesis affecting 19.8% of patients, transient dysphasia 12.3%, and permanent paresis or dysphasia in 6.6% and 1.9% of patients, respectively. CONCLUSION: MST is an effective treatment for refractory epilepsy in eloquent cortex, with greater chances of seizure freedom when portions of the focus are resected in tandem with MST. The reported rates of seizure freedom with MST are higher than those of existing neuromodulatory therapies, such as vagus nerve stimulation, deep brain stimulation, and responsive neurostimulation, though these latter therapies are supported by randomized-controlled trials, while MST is not. The reported complication rate of MST is higher than that of resection and neuromodulatory therapies. MST remains a viable option for the treatment of eloquent foci, provided a careful risk-benefit analysis is conducted.
引用
- Rolston JD, Deng H, Wang DD, et al. Multiple Subpial Transections for Medically Refractory Epilepsy: A Disaggregated Review of Patient-Level Data. Neurosurgery. 2018. PMID: 28637175. doi:10.1093/neuros/nyx311
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。